Revvity | PKI - 现金及等价物



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.21B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


现金及等价物 更改 日
Agilent USD 1.81B 49M 2026-03
Align Technology USD 1.06B 35.07M 2026-03
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Charles River Laboratories USD 191.83M 21.94M 2026-03
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Edwards Lifesciences USD 2.4B 538M 2026-03
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Laboratory Of America USD 981.1M 448.8M 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
OraSure Technologies USD 176.96M 22.31M 2026-03
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Pharma Mar EUR 48.86M 31.05M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tilray USD 264.83M 43.16M 2025-06
Waters USD 462M 125.83M 2026-03
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03